Funder: National Institutes of Health

Due Dates: May 7, 2025 (AIDS) | September 7, 2025 (AIDS) | January 7, 2026 (AIDS) | May 7, 2026 (AIDS) | June 16, 2026 (New) | July 16, 2026 (Renewal/Resubmission/Revision) | October 16, 2026 (New) | November 16, 2026 (Renewal/Resubmission/Revision) | February 16, 2027 (New) | March 16, 2027 (Renewal/Resubmission/Revision) | June 16, 2027 (New) | July 16, 2027 (Renewal/Resubmission/Revision) | October 16, 2027 (New) | November 16, 2027 (Renewal/Resubmission/Revision)

Funding Amounts: Up to $275,000 in direct costs over 2 years; no more than $200,000 in any single year.

Summary: Supports exploratory/developmental HIV/AIDS research in hearing, balance, taste, smell, voice, speech, and language within the NIDCD mission, including low-risk clinical trials.

Key Information: Only low-risk clinical trials are supported; see program notice for definition and restrictions.